Shuchen Sun

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Integrated single cell-RNA sequencing and Mendelian randomization for ischemic stroke and metabolic syndrome.

Integrated single cell-RNA sequencing and Mendelian randomization for ischemic stroke and metabolic syndrome.

Journal: iScience
Published: November 19, 2023

Peptidomics insights: neutrophil extracellular traps (NETs) related to the chronic subdural hemorrhage.

Peptidomics insights: neutrophil extracellular traps (NETs) related to the chronic subdural hemorrhage.

Journal: PeerJ
Published: August 21, 2023

Identification of potential functional peptides involved in demyelinating injury in the central nervous system.

Identification of potential functional peptides involved in demyelinating injury in the central nervous system.

Journal: PeerJ
Published: April 19, 2023

Predicting meningioma grades and pathologic marker expression via deep learning.

Predicting meningioma grades and pathologic marker expression via deep learning.

Journal: European radiology
Published: November 20, 2022

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas.

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas.

Journal: Frontiers in oncology
Published: February 19, 2022

CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis.

CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis.

Journal: Journal of molecular cell biology
Published: January 11, 2022

LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway.

LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway.

Journal: Molecules and cells
Published: September 09, 2021

m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes.

m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes.

Journal: Frontiers in oncology
Published: August 19, 2021

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy.

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy.

Journal: Frontiers in oncology
Published: July 26, 2021

The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations.

The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations.

Journal: Neuro-oncology advances
Published: July 10, 2020

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma.

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma.

Journal: Frontiers in oncology
Published: May 31, 2020

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma.

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma.

Journal: Frontiers in oncology
Published: March 12, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026